Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis
by
Loomba, Rohit
, Haupt, Axel
, Robins, Deborah A.
, Bunck, Mathijs C.
, Tang, Yuanyuan
, Hartman, Mark L.
, Vuppalanchi, Raj
, Boursier, Jérôme
, Bugianesi, Elisabetta
, Brouwers, Bram
, Behling, Cynthia
, Lawitz, Eric J.
, Cummings, Oscar W.
, Yoneda, Masato
, Nikooie, Amir
, Sanyal, Arun J.
in
Adult
/ Aged
/ Antidiabetics
/ Biomarkers
/ Biopsy
/ Clinical trials
/ Diabetes
/ Dose-Response Relationship, Drug
/ Double-Blind Method
/ Endocrinology
/ Endocrinology General
/ Fatty Liver - drug therapy
/ Female
/ Fibrosis
/ Gastric Inhibitory Polypeptide - agonists
/ Gastroenterology
/ Gastroenterology General
/ Gastrointestinal surgery
/ GIP protein
/ Glucagon
/ Glucagon-like peptide 1
/ Glucagon-Like Peptide-1 Receptor Agonists
/ Glucagon-Like Peptide-2 Receptor - agonists
/ Humans
/ Inflammation
/ Injections, Subcutaneous
/ Life Sciences
/ Liver - drug effects
/ Liver - pathology
/ Liver cirrhosis
/ Liver Cirrhosis - drug therapy
/ Liver Disease
/ Liver diseases
/ Magnetic resonance imaging
/ Male
/ Metabolism
/ Middle Aged
/ Obesity
/ Placebos
/ Software
/ Tirzepatide
2024
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis
by
Loomba, Rohit
, Haupt, Axel
, Robins, Deborah A.
, Bunck, Mathijs C.
, Tang, Yuanyuan
, Hartman, Mark L.
, Vuppalanchi, Raj
, Boursier, Jérôme
, Bugianesi, Elisabetta
, Brouwers, Bram
, Behling, Cynthia
, Lawitz, Eric J.
, Cummings, Oscar W.
, Yoneda, Masato
, Nikooie, Amir
, Sanyal, Arun J.
in
Adult
/ Aged
/ Antidiabetics
/ Biomarkers
/ Biopsy
/ Clinical trials
/ Diabetes
/ Dose-Response Relationship, Drug
/ Double-Blind Method
/ Endocrinology
/ Endocrinology General
/ Fatty Liver - drug therapy
/ Female
/ Fibrosis
/ Gastric Inhibitory Polypeptide - agonists
/ Gastroenterology
/ Gastroenterology General
/ Gastrointestinal surgery
/ GIP protein
/ Glucagon
/ Glucagon-like peptide 1
/ Glucagon-Like Peptide-1 Receptor Agonists
/ Glucagon-Like Peptide-2 Receptor - agonists
/ Humans
/ Inflammation
/ Injections, Subcutaneous
/ Life Sciences
/ Liver - drug effects
/ Liver - pathology
/ Liver cirrhosis
/ Liver Cirrhosis - drug therapy
/ Liver Disease
/ Liver diseases
/ Magnetic resonance imaging
/ Male
/ Metabolism
/ Middle Aged
/ Obesity
/ Placebos
/ Software
/ Tirzepatide
2024
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis
by
Loomba, Rohit
, Haupt, Axel
, Robins, Deborah A.
, Bunck, Mathijs C.
, Tang, Yuanyuan
, Hartman, Mark L.
, Vuppalanchi, Raj
, Boursier, Jérôme
, Bugianesi, Elisabetta
, Brouwers, Bram
, Behling, Cynthia
, Lawitz, Eric J.
, Cummings, Oscar W.
, Yoneda, Masato
, Nikooie, Amir
, Sanyal, Arun J.
in
Adult
/ Aged
/ Antidiabetics
/ Biomarkers
/ Biopsy
/ Clinical trials
/ Diabetes
/ Dose-Response Relationship, Drug
/ Double-Blind Method
/ Endocrinology
/ Endocrinology General
/ Fatty Liver - drug therapy
/ Female
/ Fibrosis
/ Gastric Inhibitory Polypeptide - agonists
/ Gastroenterology
/ Gastroenterology General
/ Gastrointestinal surgery
/ GIP protein
/ Glucagon
/ Glucagon-like peptide 1
/ Glucagon-Like Peptide-1 Receptor Agonists
/ Glucagon-Like Peptide-2 Receptor - agonists
/ Humans
/ Inflammation
/ Injections, Subcutaneous
/ Life Sciences
/ Liver - drug effects
/ Liver - pathology
/ Liver cirrhosis
/ Liver Cirrhosis - drug therapy
/ Liver Disease
/ Liver diseases
/ Magnetic resonance imaging
/ Male
/ Metabolism
/ Middle Aged
/ Obesity
/ Placebos
/ Software
/ Tirzepatide
2024
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis
Journal Article
Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis
2024
Request Book From Autostore
and Choose the Collection Method
Overview
In this phase 2 trial in patients with metabolic dysfunction–associated steatohepatitis and moderate or severe fibrosis, tirzepatide was more effective than placebo with respect to resolution of MASH without worsening of fibrosis.
Publisher
Massachusetts Medical Society
Subject
/ Aged
/ Biopsy
/ Diabetes
/ Dose-Response Relationship, Drug
/ Female
/ Fibrosis
/ Gastric Inhibitory Polypeptide - agonists
/ Glucagon
/ Glucagon-Like Peptide-1 Receptor Agonists
/ Glucagon-Like Peptide-2 Receptor - agonists
/ Humans
/ Liver Cirrhosis - drug therapy
/ Male
/ Obesity
/ Placebos
/ Software
This website uses cookies to ensure you get the best experience on our website.